$PCYN
PROCYON CORP Stock $pcyn

$pcyn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000143774924005229 Filed on February 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$1.199M	$1.200M
YoY Change	6.55%	1.36%
Cost Of Revenue	$260.8K	$263.3K
YoY Change	-1.05%	-10.27%
Gross Profit	$937.8K	$936.7K
YoY Change	8.88%	5.19%
Gross Profit Margin	78.24%	78.06%
Selling, General & Admin	$503.2K	$535.7K
YoY Change	12.65%	12.92%
% of Gross Profit	53.66%	57.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.93K	$20.88K
YoY Change	83.11%	87.43%
% of Gross Profit	2.23%	2.23%
Operating Expenses	$503.2K	$535.7K
YoY Change	12.65%	12.92%
Operating Profit	-$81.79K	-$101.4K
YoY Change	59.66%	221.49%
Interest Expense	$6.620K	$5.618K
YoY Change	71.41%	156.3%
% of Operating Profit
Other Income/Expense, Net	$15.93K	$13.98K
YoY Change	28.56%	177.6%
Pretax Income	-$65.86K	-$87.44K
YoY Change	69.58%	229.83%
Income Tax	$36.93K	$155.0K
% Of Pretax Income
Net Earnings	-$102.8K	-$242.5K
YoY Change	248.78%	1107.66%
Net Earnings / Revenue	-8.58%	-20.21%
Basic Earnings Per Share	-$0.01	-$0.03
Diluted Earnings Per Share	-$0.01	-$0.03
COMMON SHARES
Basic Shares Outstanding	8.108M	8.108M
Diluted Shares Outstanding	8.108M	8.108M

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$901.7K	$838.8K
YoY Change	2.21%	-5.35%
Cash & Equivalents	$325.1K	$267.8K
Short-Term Investments	$576.5K	$570.9K
Other Short-Term Assets	$373.0K	$228.0K
YoY Change	-18.02%	-11.2%
Inventory	$535.5K	$530.9K
Prepaid Expenses
Receivables	$481.9K	$509.6K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.292M	$2.107M
YoY Change	-4.47%	-7.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$281.1K	$301.3K
YoY Change	92.15%	93.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$270.4K	$306.8K
YoY Change	-45.33%	-34.25%
Total Long-Term Assets	$954.6K	$1.059M
YoY Change	-22.3%	-15.67%
TOTAL ASSETS
Total Short-Term Assets	$2.292M	$2.107M
Total Long-Term Assets	$954.6K	$1.059M
Total Assets	$3.247M	$3.166M
YoY Change	-10.51%	-10.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$208.4K	$208.9K
YoY Change	0.17%	58.99%
Accrued Expenses	$582.1K	$374.2K
YoY Change	30.53%	4.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$790.5K	$583.1K
YoY Change	20.87%	19.22%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$185.4K	$230.6K
YoY Change	-49.03%	-43.29%
Total Long-Term Liabilities	$206.8K	$230.6K
YoY Change	-43.14%	-43.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$790.5K	$583.1K
Total Long-Term Liabilities	$206.8K	$230.6K
Total Liabilities	$997.3K	$813.7K
YoY Change	-2.01%	-9.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.369M	-$2.266M
YoY Change	18.61%	15.16%
Common Stock	$4.450M	$4.450M
YoY Change	0.12%	0.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.249M	$2.352M
YoY Change
Total Liabilities & Shareholders Equity	$3.247M	$3.166M
YoY Change	-10.51%	-10.45%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$102.8K	-$242.5K
YoY Change	248.78%	1107.66%
Depreciation, Depletion And Amortization	$20.93K	$20.88K
YoY Change	83.11%	87.43%
Cash From Operating Activities	$58.08K	-$126.6K
YoY Change	47.79%	-263.62%
INVESTING ACTIVITIES
Capital Expenditures	$750.00	$8.130K
YoY Change	-67.81%	-51.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$750.00	-$8.130K
YoY Change	-99.73%	-51.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	58.08K	-126.6K
Cash From Investing Activities	-750.0	-8.130K
Cash From Financing Activities	0.000
Net Change In Cash	57.33K	-134.7K
YoY Change	-120.4%	-764.81%
FREE CASH FLOW
Cash From Operating Activities	$58.08K	-$126.6K
Capital Expenditures	$750.00	$8.130K
Free Cash Flow	$57.33K	-$134.7K
YoY Change	55.07%	-322.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Assets Assets	3563711	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	175057	usd
CY2023Q2	pcyn	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	277498	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	319882	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	230576	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	319882	usd
CY2023Q4	us-gaap	Liabilities Liabilities	813662	usd
CY2023Q2	us-gaap	Liabilities Liabilities	946002	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	496000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	496000000
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3341	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-89471	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-118077	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	33831	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46695	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-69662	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-111854	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-121965	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-131883	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	604752	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8187	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2659767	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-20078	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2639689	usd
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	161180	usd
CY2023Q2	pcyn	Assets Noncurrent Excluding Property Plant And Equipment AssetsNoncurrentExcludingPropertyPlantAndEquipment	1045083	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	173565	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	626120	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000812306
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1214	usd
	pcyn	Other Income And Gain Loss On Extinguishment Of Debt OtherIncomeAndGainLossOnExtinguishmentOfDebt	0	usd
CY2022Q4	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	2844	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	17916	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	2844	usd
CY2023Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5618	usd
CY2022Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2192	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	10826	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3087	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13980	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5036	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28146	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5931	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87435	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26509	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-130660	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37067	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	155038	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6431	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145668	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8802	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-242473	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-20078	usd
	us-gaap	Net Income Loss NetIncomeLoss	-276328	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28265	usd
CY2023Q4	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4172	usd
CY2022Q4	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4178	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7805	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	8355	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-246645	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24256	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-284133	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36620	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8108388
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8087388
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8108388
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8087388
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8108388
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8087388
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8108388
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8087388
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2617709	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10721	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-33855	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2594575	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-242473	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2352102	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2667954	usd
	us-gaap	Net Income Loss NetIncomeLoss	-276328	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28265	usd
	us-gaap	Depreciation Depreciation	40032	usd
	us-gaap	Depreciation Depreciation	22050	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3375	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-814	usd
	pcyn	Operating Lease Right Of Use Asset Amortization Expense Reversal OperatingLeaseRightOfUseAssetAmortizationExpenseReversal	93721	usd
	pcyn	Operating Lease Right Of Use Asset Amortization Expense Reversal OperatingLeaseRightOfUseAssetAmortizationExpenseReversal	89998	usd
	pcyn	Accrued Interest On Certificates Of Deposit AccruedInterestOnCertificatesOfDeposit	8472	usd
	pcyn	Accrued Interest On Certificates Of Deposit AccruedInterestOnCertificatesOfDeposit	314	usd
	pcyn	Deferred Income Tax Expense Benefit Gross DeferredIncomeTaxExpenseBenefitGross	-30864	usd
	pcyn	Deferred Income Tax Expense Benefit Gross DeferredIncomeTaxExpenseBenefitGross	23158	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-176532	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	31960	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-1214	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	85788	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	80331	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19030	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177745	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-4555	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	55556	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-70475	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61537	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23761	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61537	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23761	usd
	pcyn	Payments On Operating Lease Liability Financing Activities PaymentsOnOperatingLeaseLiabilityFinancingActivities	-0	usd
	pcyn	Payments On Operating Lease Liability Financing Activities PaymentsOnOperatingLeaseLiabilityFinancingActivities	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-183502	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-155644	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	451306	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	760396	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267804	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	576548	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	199125	usd
CY2023Q4	pcyn	Accrued Expenses Settled For Issuance Of Equity AccruedExpensesSettledForIssuanceOfEquity	10721	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	115000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	115000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25432
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.25
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140432
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.26
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	115000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.17
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	140432
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.25
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	618349	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	9985	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	3346	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	185370	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	817474	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	761918	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	286611	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	330513	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	248
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0397	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9037	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	863000	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-120695	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	7293	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-24973	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1509	usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-145668	usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	8802	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145668	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8802	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	218665	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6387	usd
CY2023Q4	pcyn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	103321	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4747	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	346451	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	109858	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	44549	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	154407	usd
CY2023Q4	pcyn	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	192044	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	176532	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15512	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	176532	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	176532	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2535	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2535	pure
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	27520	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7784	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5694	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1611	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-2611	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-593	usd
	pcyn	Effective Income Tax Rate Reconciliation Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardAmount	-261	usd
	pcyn	Effective Income Tax Rate Reconciliation Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardAmount	31960	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-176532	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31960	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145668	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8802	usd
CY2021Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	250000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	979744	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	546295	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	433449	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	979744	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	572085	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	407659	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	177083	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	230576	usd
CY2023Q4	us-gaap	Variable Lease Cost VariableLeaseCost	50567	usd
CY2022Q4	us-gaap	Variable Lease Cost VariableLeaseCost	50020	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	101135	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	100041	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M23D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0329	pure
CY2023Q4	us-gaap	Sublease Income SubleaseIncome	8958	usd
	us-gaap	Sublease Income SubleaseIncome	17916	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	32846	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	0	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	0	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	0	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	0	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	32846	usd

Files In Submission

Name	View Source	Status
0001437749-24-005229-index-headers.html	Edgar Link	pending
0001437749-24-005229-index.html	Edgar Link	pending
0001437749-24-005229.txt	Edgar Link	pending
0001437749-24-005229-xbrl.zip	Edgar Link	pending
ex_628573.htm	Edgar Link	pending
ex_628574.htm	Edgar Link	pending
ex_628579.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcyn-20231231.xsd	Edgar Link	pending
pcyn20231231_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pcyn-20231231_cal.xml	Edgar Link	unprocessable
pcyn-20231231_def.xml	Edgar Link	unprocessable
pcyn-20231231_lab.xml	Edgar Link	unprocessable
pcyn-20231231_pre.xml	Edgar Link	unprocessable
pcyn20231231_10q_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCYN
PROCYON CORP Stock $pcyn

2024 Q1 Form 10-Q Financial Statement

#000143774924005229 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCYN PROCYON CORP Stock $pcyn

2024 Q1 Form 10-Q Financial Statement

#000143774924005229 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCYN
PROCYON CORP Stock $pcyn